Cts [CTS] vs Bel Fuse [BELFB] Detailed Stock Comparison

Cts

Bel Fuse
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Cts wins in 14 metrics, Bel Fuse wins in 6 metrics, with 0 ties. Cts appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Cts | Bel Fuse | Better |
---|---|---|---|
P/E Ratio (TTM) | 18.80 | 35.45 | Cts |
Price-to-Book Ratio | 2.13 | 4.35 | Cts |
Debt-to-Equity Ratio | 20.66 | 57.31 | Cts |
PEG Ratio | 0.64 | 1.00 | Cts |
EV/EBITDA | 10.28 | 18.77 | Cts |
Profit Margin (TTM) | 12.32% | 8.59% | Cts |
Operating Margin (TTM) | 17.02% | 15.37% | Cts |
EBITDA Margin (TTM) | 17.02% | 15.37% | Cts |
Return on Equity | 11.96% | 14.16% | Bel Fuse |
Return on Assets (TTM) | 6.76% | 7.17% | Bel Fuse |
Free Cash Flow (TTM) | $80.65M | $59.96M | Cts |
Dividend Yield | 0.39% | 0.27% | Cts |
1-Year Return | -16.91% | 69.43% | Bel Fuse |
Price-to-Sales Ratio (TTM) | 2.24 | 2.87 | Cts |
Enterprise Value | $1.18B | $2.06B | Bel Fuse |
EV/Revenue Ratio | 2.27 | 3.47 | Cts |
Gross Profit Margin (TTM) | 38.75% | 38.67% | Cts |
Revenue per Share (TTM) | $17 | $47 | Bel Fuse |
Earnings per Share (Diluted) | $2.11 | $3.92 | Bel Fuse |
Beta (Stock Volatility) | 0.84 | 1.25 | Cts |
Cts vs Bel Fuse Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Cts | 1.06% | 3.38% | -4.80% | -6.92% | 11.67% | -22.74% |
Bel Fuse | 1.55% | 0.53% | -0.28% | 42.16% | 121.09% | 74.16% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Cts | -16.91% | -4.16% | 55.69% | 105.27% | 292.27% | 233.81% |
Bel Fuse | 69.43% | 436.17% | 1,212.74% | 571.36% | 557.29% | 296.40% |
News Based Sentiment: Cts vs Bel Fuse
Cts
News based Sentiment: MIXED
CTS Corporation launched a new product and saw some positive price movement, but also faces short-term challenges and mixed technical signals. The analyst valuation provides a positive outlook, but the recent 90-day return is negative, creating a mixed investment narrative.
Bel Fuse
News based Sentiment: POSITIVE
Bel Fuse reported a significant earnings beat and revenue growth, driving positive investor sentiment. While technical indicators are mixed and some institutional selling occurred, the overall narrative is positive due to strong financial performance and a 'Buy' consensus from analysts.
Performance & Financial Health Analysis: Cts vs Bel Fuse
Metric | CTS | BELFB |
---|---|---|
Market Information | ||
Market Cap | $1.17B | $1.77B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 174,387 | 102,315 |
90 Day Avg. Volume | 165,542 | 118,425 |
Last Close | $40.09 | $141.12 |
52 Week Range | $34.02 - $59.68 | $58.00 - $152.45 |
% from 52W High | -32.83% | -7.43% |
All-Time High | $86.25 (Dec 06, 1999) | $152.45 (Sep 18, 2025) |
% from All-Time High | -53.52% | -7.43% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.04% | 0.26% |
Quarterly Earnings Growth | 0.26% | 0.43% |
Financial Health | ||
Profit Margin (TTM) | 0.12% | 0.09% |
Operating Margin (TTM) | 0.17% | 0.15% |
Return on Equity (TTM) | 0.12% | 0.14% |
Debt to Equity (MRQ) | 20.66 | 57.31 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $18.62 | $31.96 |
Cash per Share (MRQ) | $3.40 | $4.68 |
Operating Cash Flow (TTM) | $105.22M | $64.58M |
Levered Free Cash Flow (TTM) | $66.98M | $523,125 |
Dividends | ||
Last 12-Month Dividend Yield | 0.39% | 0.27% |
Last 12-Month Dividend | $0.16 | $0.35 |
Valuation & Enterprise Metrics Analysis: Cts vs Bel Fuse
Metric | CTS | BELFB |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 18.80 | 35.45 |
Forward P/E | 16.74 | 28.13 |
PEG Ratio | 0.64 | 1.00 |
Price to Sales (TTM) | 2.24 | 2.87 |
Price to Book (MRQ) | 2.13 | 4.35 |
Market Capitalization | ||
Market Capitalization | $1.17B | $1.77B |
Enterprise Value | $1.18B | $2.06B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.27 | 3.47 |
Enterprise to EBITDA | 10.28 | 18.77 |
Risk & Other Metrics | ||
Beta | 0.84 | 1.25 |
Book Value per Share (MRQ) | $18.62 | $31.96 |
Financial Statements Comparison: Cts vs Bel Fuse
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | CTS | BELFB |
---|---|---|
Revenue/Sales | $125.77M | $152.24M |
Cost of Goods Sold | $79.22M | $93.42M |
Gross Profit | $46.55M | $58.82M |
Research & Development | $6.19M | $7.22M |
Operating Income (EBIT) | $16.74M | $22.09M |
EBITDA | $26.23M | $31.69M |
Pre-Tax Income | $16.12M | $23.79M |
Income Tax | $2.76M | $5.46M |
Net Income (Profit) | $13.37M | $18.32M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | CTS | BELFB |
---|---|---|
Cash & Equivalents | $90.29M | $65.93M |
Total Current Assets | $243.54M | $368.43M |
Total Current Liabilities | $92.43M | $111.24M |
Long-Term Debt | $107.86M | $302.34M |
Total Shareholders Equity | $538.24M | $457.94M |
Retained Earnings | $665.02M | $362.04M |
Property, Plant & Equipment | $22.62M | $24.96M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | CTS | BELFB |
---|---|---|
Operating Cash Flow | $19.57M | $23.27M |
Capital Expenditures | N/A | $-2.73M |
Free Cash Flow | $11.05M | $5.36M |
Debt Repayment | $-264.20M | $-12.50M |
Common Stock Repurchase | $-6.47M | $0 |
Short Interest & Institutional Ownership Analysis
Metric | CTS | BELFB |
---|---|---|
Shares Short | 301,723 | 361,429 |
Short Ratio | 2.25 | 3.04 |
Short % of Float | 0.01% | 0.04% |
Average Daily Volume (10 Day) | 174,387 | 102,315 |
Average Daily Volume (90 Day) | 165,542 | 118,425 |
Shares Outstanding | 30.03M | 12.54M |
Float Shares | 28.98M | 11.86M |
% Held by Insiders | 0.02% | 0.02% |
% Held by Institutions | 0.97% | 0.93% |
Dividend Analysis & Yield Comparison: Cts vs Bel Fuse
Metric | CTS | BELFB |
---|---|---|
Last 12-Month Dividend | $0.16 | $0.35 |
Last 12-Month Dividend Yield | 0.39% | 0.27% |
3-Year Avg Annual Dividend | $0.15 | $0.30 |
3-Year Avg Dividend Yield | 0.09% | 0.13% |
3-Year Total Dividends | $0.44 | $0.91 |
Ex-Dividend Date | Mar 28, 2025 | Oct 15, 2025 |